Jim Kastenmayer
Conseiller Juridique Général chez ARRIVENT BIOPHARMA, INC.
Fortune : 143 362 $ au 31/05/2024
Provenance du réseau au premier degré de Jim Kastenmayer
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
105
| Public Company | Pharmaceuticals: Major | 105 |
| Public Company | Biotechnology | 11 | |
| Public Company | Pharmaceuticals: Major | 11 | |
| Subsidiary | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jim Kastenmayer via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal President President Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PRUDENTIAL PLC | Life/Health Insurance | Director of Finance/CFO Chairman | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| UNILEVER PLC | Household/Personal Care | Director of Finance/CFO Corporate Officer/Principal | |
| LEGAL & GENERAL PLC | Multi-Line Insurance | Director/Board Member Chairman | |
| STANDARD CHARTERED PLC | Major Banks | Director/Board Member Director/Board Member | |
| SMITH & NEPHEW PLC | Medical Specialties | Director of Finance/CFO Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Graduate Degree Masters Business Admin | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer Chairman | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Director/Board Member Graduate Degree Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Purdue University | College/University | Masters Business Admin Doctorate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Director/Board Member Corporate Officer/Principal | |
| Fudan University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Director/Board Member | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| Center for Drug Evaluation & Research | General Government | Corporate Officer/Principal Director/Board Member | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer Human Resources Officer Corporate Officer/Principal | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Founder Director/Board Member Director/Board Member Chief Executive Officer | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Tufts University School of Medicine | College/University | Doctorate Degree Undergraduate Degree | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Corporate Officer/Principal | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Founder Director/Board Member | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer Director/Board Member | ||
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 33 |
| Royaume-Uni | 11 |
| Suède | 3 |
| Chine | 3 |
| France | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 4 |
| Government | 3 |
Opérationnelle
| Director/Board Member | 481 |
| Corporate Officer/Principal | 279 |
| Independent Dir/Board Member | 161 |
| Undergraduate Degree | 74 |
| Chairman | 74 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| James Healy | 50 |
| Martin MacKay | 28 |
| Anders Olof Adolf Ekblom | 27 |
| José Baselga | 27 |
| Sherilyn McCoy | 26 |
| Briggs Morrison | 26 |
| Philip Broadley | 24 |
| Mike Gutch | 24 |
| Anthony Zook | 24 |
| Ann Cairns | 20 |
| David Brennan | 19 |
| Atul Saran | 18 |
| Tyrell J. Rivers | 17 |
| Pascal Soriot | 17 |
- Bourse
- Insiders
- Jim Kastenmayer
- Connexions Sociétés
